Forsta Ap Fonden Incyte Corp Transaction History

Forsta Ap Fonden

$14.8 Billion
Q2 2025

A detailed history of Forsta Ap Fonden transactions in Incyte Corp stock. As of the latest transaction made, Forsta Ap Fonden holds 30,100 shares of INCY stock, worth $2.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,100

Previous 31,000 2.9%

Holding current value

$2.38 Million

Previous $1.88 Million 9.16%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$55.17 - $71.22 $49,653 - $64,098	-900 Reduced 2.9%	30,100 $2.05 Million
Q1 2025 May 12, 2025	SELL	$60.0 - $75.26 $4.42 Million - $5.55 Million	-73,700 Reduced 70.39%	31,000 $1.88 Million
Q4 2024 Jan 23, 2025	BUY	$65.08 - $83.38 $117,144 - $150,084	1,800 Added 1.75%	104,700 $7.23 Million
Q3 2024 Oct 24, 2024	BUY	$57.33 - $68.61 $2 Million - $2.39 Million	34,800 Added 51.1%	102,900 $6.8 Million
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $711,402 - $886,125	-13,900 Reduced 16.95%	68,100 $4.13 Million
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $2.88 Million - $3.4 Million	51,000 Added 164.52%	82,000 $4.67 Million
Q4 2023 Feb 06, 2024	BUY	$52.16 - $64.19 $1.62 Million - $1.99 Million	31,000 New	31,000 $1.95 Million
Q1 2023 Apr 21, 2023	SELL	$70.23 - $86.01 $519,702 - $636,474	-7,400 Reduced 15.91%	39,100 $2.83 Million
Q4 2022 Feb 02, 2023	BUY	$67.18 - $84.11 $208,258 - $260,741	3,100 Added 7.14%	46,500 $3.73 Million
Q3 2022 Oct 17, 2022	SELL	$66.18 - $82.86 $542,676 - $679,452	-8,200 Reduced 15.89%	43,400 $2.89 Million
Q2 2022 Aug 11, 2022	BUY	$66.18 - $83.18 $443,406 - $557,306	6,700 Added 14.92%	51,600 $3.92 Million
Q1 2022 May 09, 2022	BUY	$66.02 - $79.71 $2.96 Million - $3.58 Million	44,900 New	44,900 $3.57 Million
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $2.57 Million - $3 Million	-40,500 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $2.6 Million - $3.18 Million	37,800 Added 1400.0%	40,500 $2.79 Million
Q2 2021 Aug 12, 2021	SELL	$79.87 - $87.53 $3.29 Million - $3.61 Million	-41,200 Reduced 93.85%	2,700 $227,000
Q1 2021 May 11, 2021	SELL	$76.02 - $100.5 $1.33 Million - $1.76 Million	-17,500 Reduced 28.5%	43,900 $3.57 Million
Q4 2020 Feb 09, 2021	BUY	$80.74 - $97.7 $2.65 Million - $3.2 Million	32,800 Added 114.69%	61,400 $5.34 Million
Q3 2020 Feb 19, 2021	BUY	$85.07 - $109.69 $2.43 Million - $3.14 Million	28,600 New	28,600 $2.57 Million
Q3 2020 Oct 22, 2020	SELL	$85.07 - $109.69 $2.01 Million - $2.59 Million	-23,600 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $29,672 - $43,572	-400 Reduced 1.67%	23,600 $2.45 Million
Q1 2020 May 04, 2020	BUY	$63.18 - $85.97 $1.52 Million - $2.06 Million	24,000 New	24,000 $1.76 Million

Others Institutions Holding INCY

# of Institutions

708

Shares Held

196M

Call Options Held

564K

Put Options Held

317K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account